Rights and permissions
About this article
Cite this article
Is using PHI for prostate cancer diagnosis in Europe worth it?. Pharmacoecon. Outcomes News 649, 4 (2012). https://doi.org/10.2165/00151234-201206490-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206490-00013